Highlight
- ASAP-TOO evaluated left atrial appendage closure (LAAC) for patients with atrial fibrillation (AF) unsuitable for oral anticoagulation (OAC).
- LAAC implantation success was high (97.8%) with low periprocedural complications.
- Over 5 years, ischemic stroke or systemic embolism rates trended lower with LAAC but were not statistically significant due to early trial termination and underpowering.
- Major bleeding was numerically higher in the LAAC group, primarily during the first 3 months due to mandated antiplatelet therapy.
Study Background
Specialty calculators
For clinical reference; use professional judgment.
